Pricing Log in Create free account
Saturday 17 October 2026 Export PFE’s income statement to Excel — free account

Pfizer Inc.

PFE Healthcare Drug Manufacturers General

Pfizer Inc.’s revenue for fiscal 2025 (year ended December 2025) was $62.6 billion, down 1.65% from fiscal 2024. In the quarter to June 2026, revenue grew 2.60%, EPS fell 107.8%, free cash flow grew 125.2% and total debt rose 2.26%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years; insiders bought in the last twelve months.

29.58 0.14 +0.48%
Market cap
$167.8B
P/E
38.9×
Fwd P/E
12.2×
Dividend yield
5.81%
F-score
6/9
Altman Z
2.03
Beneish M
−2.52
Dividend safety
28/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Pfizer Inc. (PFE) P/S ratio

Alert me on P/S ratio

As of 16 October 2026, Pfizer Inc. (PFE) trades at a P/S ratio of 2.6×. Over the past ten years it has ranged from 2.0× (April 2025) to 7.4× (December 2020); the current reading is higher than 28% of that period. That is below the Drug Manufacturers General industry median of 3.4× and below the Healthcare sector median of 3.4×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 2.3× (4.26%)
FY2024 2.4× (16.17%)
FY2023 2.8× (0.85%)
FY2022 2.8× (30.17%)
FY2021 4.1× (17.12%)
FY2020 4.9× (2.99%)
FY2019 5.1× (15.04%)
FY2018 6.0× 51.64%
FY2017 3.9× 8.83%
FY2016 3.6× (6.80%)

Quarterly newest first

Period P/S ratio Change
Jun 2026 2.2× (14.64%)
Mar 2026 2.5× 11.62%
Dec 2025 2.3× (1.99%)
Sep 2025 2.3× 6.87%
42 more quarters

Against its own ten years

Low 2.0× High 7.4×
Ten-year median 3.7×
Current reading's percentile 30

P/S ratio against peers

Company P/S ratio
SNY Sanofi compare 1.7×
GSK GSK PLC Sponsored ADR compare 2.2×
BMY Bristol Myers Squibb Company compare 2.5×
PFE Pfizer Inc. 2.6×
NVO Novo Nordisk A/S compare 3.3×
AZN AstraZeneca PLC compare 4.2×
NVS Novartis AG compare 5.1×
AMGN Amgen Inc. compare 6.1×
GILD Gilead Sciences, Inc. compare 6.4×
Drug Manufacturers General industry median 3.4×
Healthcare sector median 3.4×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on PFE